This compound is primarily utilized in the field of medicinal chemistry and pharmaceutical research. It serves as a key intermediate in the synthesis of biologically active molecules, particularly those targeting specific enzymes or receptors involved in disease pathways. Its structural features make it a valuable scaffold for developing potential therapeutic agents, especially in the treatment of cancer and inflammatory disorders. Researchers often modify its core structure to enhance its pharmacological properties, such as improving bioavailability, selectivity, and potency. Additionally, it is explored in the development of proteolysis-targeting chimeras (PROTACs), a novel approach in drug discovery aimed at degrading disease-causing proteins. Its application extends to preclinical studies, where it is used to evaluate efficacy and safety profiles in various disease models.